Thrivent Financial for Lutherans Cuts Stock Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Thrivent Financial for Lutherans lowered its stake in shares of Molina Healthcare, Inc. (NYSE:MOH – Get Rating) by 28.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,501 shares of the company’s stock after selling 1,004 shares during the period. Thrivent Financial for Lutherans’ holdings in Molina Healthcare were worth $826,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. JGP Global Gestao de Recursos Ltda. lifted its position in shares of Molina Healthcare by 3.8% in the 3rd quarter. JGP Global Gestao de Recursos Ltda. now owns 847 shares of the company’s stock worth $279,000 after buying an additional 31 shares during the last quarter. KBC Group NV increased its stake in Molina Healthcare by 0.5% in the 3rd quarter. KBC Group NV now owns 6,334 shares of the company’s stock valued at $2,089,000 after buying an additional 33 shares during the period. Captrust Financial Advisors grew its position in Molina Healthcare by 0.5% in the second quarter. Captrust Financial Advisors now owns 6,315 shares of the company’s stock worth $1,766,000 after acquiring an additional 33 shares in the last quarter. Lmcg Investments LLC boosted its holdings in shares of Molina Healthcare by 1.4% during the 3rd quarter. Lmcg Investments LLC now owns 2,523 shares of the company’s stock worth $832,000 after buying an additional 35 shares during the period. Finally, Meiji Yasuda Asset Management Co Ltd. raised its stake in Molina Healthcare by 4.3% during the 3rd quarter. Meiji Yasuda Asset Management Co Ltd. now owns 921 shares of the company’s stock valued at $304,000 after purchasing an additional 38 shares during the last quarter. Hedge funds and other institutional investors own 94.25% of the company’s stock.

Molina Healthcare Stock Performance

Shares of MOH stock opened at $281.74 on Thursday. The business’s 50 day simple moving average is $283.62 and its 200 day simple moving average is $300.34. Molina Healthcare, Inc. has a one year low of $249.78 and a one year high of $374.00. The stock has a market capitalization of $16.43 billion, a PE ratio of 19.19, a PEG ratio of 1.08 and a beta of 0.68. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.47 and a quick ratio of 1.47.

Molina Healthcare (NYSE:MOH – Get Rating) last posted its quarterly earnings results on Wednesday, April 26th. The company reported $5.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.13 by $0.68. The firm had revenue of $8.15 billion for the quarter, compared to analysts’ expectations of $8.31 billion. Molina Healthcare had a return on equity of 36.20% and a net margin of 2.64%. The company’s revenue for the quarter was up 4.9% compared to the same quarter last year. During the same period in the prior year, the business earned $4.90 EPS. As a group, research analysts forecast that Molina Healthcare, Inc. will post 20.25 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on MOH shares. Wells Fargo & Company cut their target price on shares of Molina Healthcare from $307.00 to $282.00 and set an “underweight” rating for the company in a research note on Tuesday, March 21st. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Molina Healthcare from $365.00 to $335.00 in a research note on Monday, May 8th. JPMorgan Chase & Co. dropped their target price on shares of Molina Healthcare from $360.00 to $348.00 and set an “overweight” rating for the company in a research report on Thursday, February 23rd. Credit Suisse Group increased their price objective on shares of Molina Healthcare from $347.00 to $350.00 in a report on Friday, April 28th. Finally, Stephens reaffirmed an “equal weight” rating and issued a $375.00 target price on shares of Molina Healthcare in a research note on Thursday, February 9th. One analyst has rated the stock with a sell rating, four have issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Molina Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $354.75.

Insider Activity

In other news, Director Daniel Cooperman sold 5,000 shares of the stock in a transaction on Friday, March 3rd. The stock was sold at an average price of $276.77, for a total transaction of $1,383,850.00. Following the completion of the transaction, the director now owns 4,944 shares in the company, valued at approximately $1,368,350.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.10% of the company’s stock.

Molina Healthcare Profile

(Get Rating)

Molina Healthcare, Inc engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.